An IL8 concentration of 73 ng/L in CSF was identified as cut-off to differentiate patients with GBS from those with CIDP, and 51 ng/L to differentiate CIDP and PDN from non-inflammatory polyneuropathies (Figure 3). The gene discussed is CXCL8; the disease is Guillain-Barre syndrome.